More About Kris
Kris Tatiossian, PhD, is the content lead, life sciences, on the Bio + Health team. She specializes in transforming complex scientific topics into accessible narratives. In this role, she oversees the brand’s digital strategy from podcasts, blogs, and newsletters to social media, bringing subjects like biotechnology and artificial intelligence to a broader audience. Working closely with different teams, Kris harmonizes the content creation journey from brainstorming to final delivery, ensuring that the brand message remains cohesive and relevant.
Before joining Bio + Health, Kris served as the Founder/CEO of CRISPR Classroom and President of Arkitekt Bio. These experiences provided her with a broad understanding of entrepreneurship, strategic communication, and educational outreach, skills she applies in her current position.
Kris holds a PhD in Medical Biology from the University of Southern California and a Bachelor of Science in Entomology from the University of California, Davis. Off the clock, she enjoys adding to her insect collection, camping, and cooking.
Julie Klapstein, founding CEO of Availity, long-time healthcare executive, and a16z Bio + Health's newest advisory partner, joins Julie Yoo, general partner at a16z Bio + Health.
Scribe Therapeutics cofounder and CEO Ben Oakes joins a16z Bio + Health founding general partner Vijay Pande.
Josh Clemente, cofounder and president of Levels, joins Vijay Pande, founding general partner, and Daisy Wolf, investment partner at a16z Bio + Health.
Former gymnast and current investor Aly Raisman joins general partner Julie Yoo and investment partner Daisy Wolf of a16z Bio + Health.
Max Cohen, cofounder and CEO of Sprinter Health, and Eren Bali, founder and CEO of Carbon Health, join Julie Yoo, general partner at a16z Bio + Health.